I will just start of by saying thank you to all for the great reporting by holders from
the Sydney and Melbourne presentations.Melbourne presentation that I attended was top notch, there was a good vibin the room and to say Dr Yuman Fong looked confident is a big understatement.Let's go back to last year when Dr Yuman Fong came out to Australia for his firstpresentation on the CF33 platform. Back then he stated that he was hopeful thatthe early phase one trails would show safety is no problem, as he mentioned atthat point himself that its one thing to prove it on rodents but its another thing toprove safety on humans. Then came his second visit to Australia earlier this year.This time he was very pleased with the safety margin that they had to play with,and basically said he had not seen anything like this before, strong words from aman of his experience in the field. He also gave us all an indication that the viruswas behaving exactly like it should and doing its job like it should. Even at thisextremely low dose.This time on his third visit, he is beaming with conference in my opinion. I thinkall that were present at the presentation could see he would love to tell us more, buthe is restricted because he has to wait for all the data to be collected and then it needsto be third party verified.Just my gut feel after taking to him with a few others after the presentation is that theresults are going to be spectacular. I'm say this because he told us in no uncertain termsthat he is very much convinced that this will go on and be the preferred treatment incombination with multiple other approved FDA treatments already on the market and evenon its own eventually. It is clear in my view that they know the results and that theyare already in talks with big pharmaceuticals.Big pharma are just waiting for more confirmation that everything is A OK, with theadded data down the track and then its action time, just my opinion.Also, there has been a little change in there language in regards to acquisitions asDickyB has mentioned. It has all been about licencing the IP right across the boardbefore this presentation, but if I was to guess, I think they would like to sell of partsof the Bcell platform to different parts of the world and then go on and licence theCF33 platform to every Tom Dick and Harry so to speak. They could even sell ofthe hole Bcell platform to just one big Pharma. Now wouldn't that be good, sellit off and all shareholders would receive a big fat dividend and IMU then go on and bea big Pharma themselves with multiple deals across multiple drugs for the CF33platform. Big massive dividends for the next 15 years plus.All in all, Dr Yuman Fong has basically given us the indication that everything is going toplan and the virus is doing as it was designed to do and turn cold tumors into hot tumorsand then killing of the cancer cells. Yes, that's right we could be seeing CF33 becoming aSoC one day, a monumental shift in cancer treatment. A universal platform for tumortargeting and killing, as Yuman has mentioned many times, not as far fetched as you think.As for the CEO and Managing Director Leslie Chong saying she would probably beelsewhere in three years time. Well if that's not a give away that they are heavily intalks with big Pharama I don't know what is. I think what she is insinuating there isthat in three years time her job will be finished, all acquisitions of IP completedand CF33 multiple licencing completed.Then we shareholders site back and watch the big bucks come in with dividends,and the best part of it all is that in some small way all shareholders have played a little partin saving so many lives around the world. That would be a really beautiful thing would it not?God bless them all in there fight against this shocking thing called cancer.This is just my opinion and not investment advice.GLTAH
- Forums
- ASX - By Stock
- Ann: Imugene Corporate Presentation
I will just start of by saying thank you to all for the great...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |